48 overseas drugs set for patient use on Chinese mainland this yeawalt disney 2015rCustom Silicone Bracelets And Wristbands Swiss Legend Watches are known as their style and durability, and anyone is to be proud to receive one as a variety of on a wedding day. Purchasing one for yourself also are a thrill. To understand standout models before you purchase your next watch. Doing a substantial rummage sale or yard sale in the church automobile parking space on "life was imple" is a fun way raise funds. You may get people to give their items for a broad sale, sell tables in the form of flea market does, actually let people sell things from their trunks for a small charge. Put out a general call for items and let parishioners know that you get to send a crew around with a truck for giant items because of the attic or garage.
China"s top drug authority said it has been accelerating approval of new drugs researched and developed overseas, and a number of such new drugs will be available for patient use on the Chinese mainland this year.
The National Medial Products Administration released a list at the end of last year of 48 overseas new drugs, including 12 cancer drugs, for priority approval, and eight have been available in the domestic market, the administration said, China Central Television reported on Monday.
All these drugs are already available in overseas markets, and they are urgently needed by domestic patients, it said.
The administration will recognize research data conducted by developers of the drugs overseas, and give approval to the drugs as long as their applicants believe the drugs will not cause different safety risks and effects to peoples of different races, the administration said.
Meanwhile, the administration also is improving information exchanges with drug researchers and developers, which has facilitated drug research and development, it said.
The administration accepted more than 1,500 requests for exchanges from drug developers, including more than 600 requests from developers of cancer drugs, by Dec 10, it said.
China has been simplifying inspection and approval procedures of overseas new drugs so they can be available in China more quickly. The administration would recognize data of clinical trials conducted outside China in the approval of new drugs, according to a guideline released by the administration last year.
Previously, such data was not recognized by the administration, so lengthy clinical trials had to be conducted in China again before drugs could be approved, even though they had been available for use overseas for years. This was a cause for delay in the availability of many new drugs in the Chinese market.